Cabot Corporation — Form 10-Q Summary
Business context and period. This filing covers Cabot’s first quarter of fiscal 2015, the three months ended December 31, 2014, compared with the same period in fiscal 2014. Cabot sells specialty chemicals and materials through Reinforcement Materials, Performance Chemicals, Purification Solutions and Specialty Fluids. The company realigned its reporting segments in December 2014 and recast prior-period segment results. The Security Materials business, sold in July 2014, is presented as discontinued operations.
Key financial results
| Metric | Q1 FY2015 | Q1 FY2014 |
|---|---|---|
| Net sales and other operating revenues | $812 million | $898 million |
| Gross profit | $157 million | $179 million |
| Income from operations | $64 million | $87 million |
| Income before tax and equity earnings | $51 million | $109 million |
| Net income attributable to Cabot | $45 million | $80 million |
| Diluted EPS | $0.69 | $1.23 |
| Cash from operating activities | $56 million | $(18) million |
- Sales declined about 10%; gross profit fell about 12%. Calculated gross margin was approximately 19.3%, versus 19.9% a year earlier. Operating margin was approximately 7.9%, versus 9.7%.
- Management attributed the $86 million sales decline primarily to lower volumes ($40 million), unfavorable price and product mix ($16 million), and foreign-currency translation ($27 million). Lower volumes reflected soft demand in South America and Europe and customer inventory destocking.
- Segment EBIT was $97 million, down from $114 million. Reinforcement Materials EBIT fell to $53 million from $73 million; Performance Chemicals rose to $39 million from $37 million; Purification Solutions improved to a $1 million loss from a $9 million loss; Specialty Fluids declined to $6 million from $13 million.
- Other expense was $1 million, compared with $35 million of other income in the prior-year quarter. The prior period included a $29 million noncash gain on Cabot’s previously held NHUMO investment and a $6 million foreign-currency gain.
Cash, debt and liquidity
- Cash and cash equivalents were $88 million at December 31, 2014, up from $67 million at September 30, 2014. Cash from operations was $56 million; investing activities used $44 million, including $41 million of capital expenditures; financing activities provided $24 million. The exchange-rate effect reduced cash by $15 million.
- Debt and notes payable totaled approximately $1.155 billion, compared with approximately $1.072 billion at September 30. Notes payable included $147 million of commercial paper. Cash plus available revolving-credit capacity was $691 million: $88 million cash and $603 million available. Management reported compliance with the credit agreement’s debt-to-EBITDA covenant.
- The revolving credit agreement is $750 million and matures in October 2019, with two one-year extension options. Management expects available cash, operating cash flow, the credit facility and commercial-paper program to meet foreseeable needs.
- Capital expenditures for the remainder of fiscal 2015 were expected to be $100–$150 million. The company repurchased 925,700 shares for $47 million in the quarter and paid $14 million of common dividends; the quarterly dividend was $0.22 per share.
Changes, outlook and material items
- Segment EBIT decreased $17 million. Lower volumes, higher fixed costs and a prior-year elastomer-composites technology milestone payment were partly offset by higher unit margins.
- A foreign pension-plan transfer to a multi-employer plan generated an $18 million pretax settlement charge, recorded primarily in cost of sales. This was a major contributor to lower gross profit.
- The income-tax provision was $3 million, an effective rate of 5%, including $13 million of net discrete tax benefits. Management’s fiscal 2015 operating tax-rate outlook was 27%–29%; tax audits could affect future tax expense and the effective rate.
- Management expected most of the EMEA service-center transition from Belgium to Latvia to be completed by fiscal year-end. Total cash charges were estimated at approximately $25 million; $22 million had been recorded through December 31, with further payments expected.
- Purification Solutions had $452 million of goodwill. Its fair value exceeded carrying value by approximately 9% in the May 2014 annual test. Future performance depends in part on expected activated-carbon demand and margins for mercury removal. MATS requirements were scheduled to begin taking effect in April 2015, while a U.S. Supreme Court review of EPA regulatory authority created uncertainty; a material change could lead to impairment charges.
- Other identified risks include raw-material costs and availability, demand and customer inventory levels, foreign exchange, project execution, Venezuela’s currency and convertibility environment, and litigation and environmental matters. Environmental reserves were $17 million; the respirator-claim reserve was $12 million, with approximately 41,000 pending claimants. Management stated that reasonably possible additional environmental costs were expected to be immaterial, and that other ordinary-course claims were not expected in aggregate to materially adversely affect financial position.
Most important facts for investors to verify
- Whether volume weakness and customer destocking persist, particularly in Reinforcement Materials and Specialty Fluids, and whether margin improvements offset lower volumes.
- Actual fiscal 2015 capital spending, operating cash conversion, and debt levels following share repurchases and planned investments.
- Purification Solutions’ sales, margins and goodwill assumptions as MATS implementation and related legal developments evolve.
- Progress and remaining cash costs of the EMEA service-center transition and other restructuring actions.
- Changes in tax-audit outcomes, Venezuela-related recoverability or currency exposure, and estimates for environmental and respirator liabilities.